517 related articles for article (PubMed ID: 6808516)
21. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
Hirschhorn R; Ratech H
Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
[No Abstract] [Full Text] [Related]
22. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
Hirschhorn R
Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
[No Abstract] [Full Text] [Related]
23. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
[TBL] [Abstract][Full Text] [Related]
24. Inherited immunodeficiency diseases: relationship to lymphocyte metabolic dysfunction.
Giblett ER; Polmar SH
Prog Med Genet; 1979; 3():177-219. PubMed ID: 118484
[No Abstract] [Full Text] [Related]
25. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
26. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
Thompson LF; Willis RC; Stoop JW; Seegmiller JE
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
[TBL] [Abstract][Full Text] [Related]
27. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
[TBL] [Abstract][Full Text] [Related]
28. Modulation of adenine nucleoside excretion and incorporation in adenosine deaminase deficient human lymphoma cells.
Iizasa T; Kubota M; Carson DA
Biochem Biophys Res Commun; 1984 Jun; 121(2):514-20. PubMed ID: 6428410
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
North ME; Newton CA; Webster AD
Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
[TBL] [Abstract][Full Text] [Related]
30. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
Chan TS
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
[TBL] [Abstract][Full Text] [Related]
31. Enzyme defects in purine metabolism and immunodeficiencies.
Ito K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
[No Abstract] [Full Text] [Related]
32. Lack of inhibition of purine nucleoside phosphorylase and adenosine deaminase in patients treated with azathioprine.
Maddocks JL; Al-Safi SA
Br J Clin Pharmacol; 1985 Jan; 19(1):108-11. PubMed ID: 3919749
[TBL] [Abstract][Full Text] [Related]
33. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
Seegmiller JE
Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
[No Abstract] [Full Text] [Related]
34. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
[TBL] [Abstract][Full Text] [Related]
35. [Immune deficiencies secondary to enzymopathies].
Pérignon JL; Hamet M
Ann Pediatr (Paris); 1989 Jun; 36(6):381-5. PubMed ID: 2502942
[TBL] [Abstract][Full Text] [Related]
36. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
Hershfield MS; Kredich NM
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
[TBL] [Abstract][Full Text] [Related]
37. Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency.
Ito K; Sakura N; Usui T; Uchino H
J Lab Clin Med; 1977 Nov; 90(5):844-8. PubMed ID: 409794
[TBL] [Abstract][Full Text] [Related]
38. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
Zegers BJ; Stoop JW
Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
[TBL] [Abstract][Full Text] [Related]
39. Enzyme defects and immune dysfunction.
Rosen FS
Nature; 1978 Dec; 276(5688):559-60. PubMed ID: 102999
[No Abstract] [Full Text] [Related]
40. Immunological aspects of purine metabolism.
Seegmiller JE; Watanabe T; Shreier MH; Waldmann TA
Adv Exp Med Biol; 1977; 76A():412-33. PubMed ID: 193375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
